New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 1 year, 8 months ago by .
-
- Topic
- Voices
- Last Post
-
- The characterization of ERBB family mutations in Chinese biliary tract cancers.
- 1
- 5 years, 2 months ago
- Tumor mutation burden in biliary tract cancers with ERBB family or DNA damage re
- 1
- 5 years, 2 months ago
- Novel staging system using carbohydrate antigen (CA) 19-9 in extrahepatic cholan
- 1
- 5 years, 2 months ago
- Retrospective analysis of outcomes in patients with non metastatic cholangiocarc
- 1
- 5 years, 2 months ago
- Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA
- 1
- 5 years, 2 months ago
- Clinical and molecular features of patients with cholangiocarcinoma harboring FG
- 1
- 5 years, 2 months ago
- A novel subpopulation of circulating tumor cells in patients with cholangiocarci
- 1
- 5 years, 2 months ago
- Non-invasive detection of acquired resistance to FGFR inhibition in patients wit
- 1
- 5 years, 2 months ago
- Comprehensive genomic profiling in FIGHT-202 reveals the landscape of actionable
- 1
- 5 years, 2 months ago
- Association of liver-directed local therapy with overall survival in metastatic
- 1
- 5 years, 2 months ago
- CT-based radiogenomic signature to identify isocitrate dehydrogenase (IDH)1/2 mu
- 1
- 5 years, 2 months ago
- Health-related quality-of-life in patients with cholangiocarcinoma: Results of a
- 1
- 5 years, 2 months ago
- A novel preclinical model of cholangiocarcinoma based on human aberrant FBXW7 ex
- 1
- 5 years, 2 months ago
- The forum ‘New Developments’ is closed to new topics and replies.